Minerva gastroenterology
The role of fecal calprotectin in assessing response to advanced medical treatments for inflammatory bowel diseases: a review of the literature.
Alessandro Vitello, Olga M Nardone, Giulio Calabrese, Salvatore M Carnazzo, Carlo D Maida, Daryl Ramai, Antonio Facciorusso, Federico Bonomo, Marcello Maida
Published: 202510.23736/S2724-5985.25.03887-2
Abstract
INTRODUCTION: In the era of treat-to-target (T2T), there is an urgent need for surrogate non-invasive markers to monitor patients with inflammatory bowel diseases (IBD). Fecal calprotectin (FC), a non-invasive biomarker reflecting intestinal inflamma…
Preview only. Read the full abstract at the source